GAtherton

🌬️ Living with Asthma and Aspergillosis: Understanding the Overlap, the Immune System, and the Right Treatment

If you live with asthma and have been told you also have aspergillosis, such as ABPA (Allergic Bronchopulmonary Aspergillosis) or SAFS (Severe Asthma with Fungal Sensitisation), your situation is more complex than most people realise.

This guide explains:

  • The different types of asthma

  • How aspergillosis complicates asthma

  • The role of eosinophils, IgE, and the immune system

  • Why some people don’t have “typical” symptoms (like wheeze)

  • What treatments are available — and how to personalise your care

🧠 Asthma Isn’t One Disease

Asthma is a condition where the airways (breathing tubes) become:

  • Inflamed (swollen and irritated)

  • Overreactive to certain triggers (allergens, cold air, infection, etc.)

  • Narrowed and often filled with mucus, making breathing difficult

But not everyone with asthma has the same cause, symptoms, or treatment response. Asthma actually includes many subtypes — and understanding your type is key to getting the right care.

🧬 Common Asthma Types in Aspergillosis

Asthma Type Cause / Trigger Key Features
Allergic asthma IgE-driven allergy to pollen, dust, pets, fungi Common in early-life asthma
Eosinophilic asthma High levels of eosinophils (a white blood cell) Often adult-onset and hard to control
SAFS Allergy to fungi (especially Aspergillus) Severe, steroid-resistant asthma
ABPA Allergic reaction to Aspergillus growing in lungs Very high IgE, eosinophils, mucus, lung damage
Cough-variant asthma Inflammation without wheeze Dry cough as the only symptom
“Silent” asthma Reduced or absent warning signs No wheeze, may present with fatigue, cough or breathlessness only

🫢 New Section: What Is “Silent Asthma”?

“Silent asthma” is not an official medical term, but it’s used to describe:

  • Asthma without the classic wheeze (often just cough or tightness)

  • Or where asthma attacks happen suddenly, without clear warning

This is important because:

  • People may not realise they have asthma

  • Diagnosis may be delayed or missed

  • Flare-ups can be severe or even life-threatening

  • It may occur in people with fungal asthma, ABPA, or airway damage

Silent asthma is especially relevant in:

  • Older adults

  • People with ABPA or SAFS

  • People with cough-variant asthma

  • Anyone whose asthma doesn’t “sound” typical

🧪 Tests like FeNO, spirometry, and blood eosinophil counts are vital for confirming what’s really happening inside the lungs — even if symptoms are subtle.

🔬 Why ABPA Adds Complexity

If you have ABPA, the asthma symptoms are made worse by:

  • A hypersensitive immune reaction to Aspergillus fumigatus

  • Mucus plugging and blocked airways

  • Lung damage (bronchiectasis) that doesn’t improve with inhalers alone

  • A mix of allergic and eosinophilic inflammation

Key signs include:

  • Extremely high IgE levels

  • Raised eosinophils

  • Positive blood tests for Aspergillus

  • Lung CT scan changes

💊 Treatment Options Based on Asthma Type

Treatment Used For
Inhaled corticosteroids (ICS) All types, first-line
Antifungal medications ABPA, SAFS
Oral steroids (e.g. prednisolone) ABPA flares, severe asthma
Biologics (e.g. mepolizumab, omalizumab) Severe allergic or eosinophilic asthma
Chest physiotherapy Mucus clearance in ABPA or bronchiectasis

Each treatment is tailored based on whether your asthma is driven by:

  • IgE (allergy)

  • Eosinophils (inflammation)

  • Fungal exposure or colonisation

📍 What to Discuss with Your Healthcare Team

If you:

  • Have asthma that isn’t well controlled

  • Need frequent steroids

  • Have a chronic cough, thick mucus, or lung damage

  • Have high IgE or eosinophils

  • Or don’t wheeze, but still get breathless or fatigued…

… it’s important to ask your doctor:

  • Could I have ABPA or SAFS?

  • Is there a fungal or eosinophilic component to my asthma?

  • Should I be tested for Aspergillus allergy or IgE?

  • Am I a candidate for biologics or antifungals?

✅ Final Takeaway

Asthma with aspergillosis is more than just “bad asthma” — it’s a complex condition involving allergy, inflammation, fungal exposure, and in some cases, permanent airway changes. Some patients don’t experience wheeze — this is called “silent asthma,” and it deserves just as much attention.

You don’t have to manage this alone — and there are now targeted treatments that can help reduce symptoms, prevent damage, and improve quality of life.

by GAtherton

Telecare Devices and the UK Digital Switchover: What Aspergillosis Patients and Carers Need to Know

Background By the end of 2025, traditional landline telephone networks in the UK will be phased out and replaced by digital (VoIP) systems delivered via broadband. This national "Digital Switchover" affects anyone using landline-based devices, including many telecare systems vital to people with chronic illnesses like chronic pulmonary aspergillosis (CPA), ABPA, and SAFS.

This document provides clear guidance for aspergillosis patients and carers concerned about how this change affects telecare equipment such as fall alarms, pendant buttons, and GPS trackers.

Why This Matters for Aspergillosis Patients Many people with aspergillosis rely on telecare to remain safe at home. These may include:

  • Fall detectors
  • Emergency pendant alarms
  • Door sensors
  • GPS trackers
  • Daily wellbeing check-in devices

These systems were typically connected to analogue landlines. Once the switch to digital phone lines is made, some older devices may stop working correctly unless they are upgraded or adapted.

What Changes with the Digital Switchover?

Feature Current (Analogue Landline) Future (Digital via Broadband)
Phone line works during power cuts Yes No (unless battery backup is added)
Telecare devices plug into phone socket Yes Only with compatible router or adapter
Works independently of broadband Yes No, relies on internet connection

Common Concerns and Solutions

  1. "Will my current telecare alarm still work?"
    • Possibly not. Many older alarms won't function over digital broadband lines.
    • Solution: Ask your alarm provider if your device is VoIP compatible or if they can supply a digital-ready or cellular version.
  2. "Will full fibre broadband stop my telecare from working?"
    • Not automatically, but older devices may be incompatible.
    • Solution: If switching to full fibre, ensure your telecare system can plug into the new router or ask about an analogue telephone adapter (ATA) with battery backup.
  3. "What happens during a power cut?"
    • Digital lines go down unless you have a UPS (Uninterruptible Power Supply) or the telecare device is cellular-based.
  4. "Can I upgrade to something more future-proof?"
    • Yes. Many councils and private providers now offer mobile-enabled alarms with built-in SIM cards and GPS.
    • These do not rely on landlines or home Wi-Fi.

What You Should Do Now

  1. Contact your telecare provider
    • Ask if your current device is digital-compatible.
    • Request upgrade options if needed.
  2. Speak to your broadband provider
    • Let them know you use telecare. Ask about battery backup or compatibility.
  3. Contact your local Adult Social Care team
    • Many councils are offering free or subsidised upgrades to digital or mobile telecare.
  4. Test your system
    • Before and after switching broadband providers, run a test call with your alarm provider.

Summary As the UK phases out analogue landlines, it's essential for patients and carers to act early. Ensuring your telecare system is compatible with digital broadband will help maintain your independence and safety. Monitoring your oxygen saturation may also support early detection of lung health changes.

Resources for Further Help

If you have questions or need help contacting the right services, the National Aspergillosis Centre support team can guide you.

by GAtherton

📄 Why Might My Posaconazole Levels Be Undetectable?

Understanding Antifungal Monitoring in Aspergillosis Treatment

If you’re taking posaconazole to treat Aspergillus-related conditions like ABPA (Allergic Bronchopulmonary Aspergillosis) or CPA (Chronic Pulmonary Aspergillosis), your doctor may ask for blood tests to check if the drug is reaching the right levels in your body.

Sometimes, those tests come back showing “undetectable” or “very low” levels, even when you’ve been taking the medication exactly as prescribed.

This can be worrying — but there are several common reasons this happens, and it doesn’t always mean the medicine isn’t working or that you’ve done something wrong.

❓ What Is Posaconazole?

Posaconazole is an antifungal medicine used to treat infections caused by the Aspergillus fungus. It comes in tablet, liquid, or IV forms. Most people take the tablet once a day — often for many weeks or months.

To work properly, the drug needs to reach a certain level in your bloodstream. This is why your team may request a blood test to check how well your body is absorbing it.

🔍 Reasons Your Posaconazole Levels May Be Low or Undetectable

1. Not Enough Fat in Your Diet

Posaconazole needs some fat in your meal to be absorbed properly — especially the liquid version.
Try to take it with a meal that includes:

  • Dairy (cheese, yoghurt, full-fat milk)

  • Eggs, nuts, or oily fish

  • A little olive oil or butter in cooking

Tip: Never take it on an empty stomach!

2. Other Medications or Supplements

Some medications and remedies can reduce how well posaconazole is absorbed, including:

  • Proton pump inhibitors (e.g. omeprazole, lansoprazole)

  • Antacids

  • Rifampicin

  • Herbal supplements like St John’s Wort

Let your doctor or pharmacist know about everything you take — even vitamins and over-the-counter products.

3. Timing of the Blood Test

The blood test should be taken just before your next dose (called a trough level).
If it’s taken too early (after a fresh dose), or too late (if you missed a dose), it may give a misleading result.

4. Problems with Absorption

Some medical conditions can make it harder for your body to absorb medications, including:

  • Coeliac disease

  • Crohn’s or colitis

  • Chronic diarrhoea or digestive issues

If you have any of these, your doctor may suggest an alternative form — like switching from liquid to tablet or tablet to IV.

5. Lab or Sample Error

Occasionally, there may be a problem with the blood sample — like a delay in handling, or a lab processing issue. In that case, your team may simply repeat the test.

✅ What You Can Do

✔️ Take your medicine with food (especially with fat)
✔️ Tell your team about other medications
✔️ Check which form you’re taking (tablets are usually better absorbed than the liquid)
✔️ Ask when your blood test should be done
✔️ Don’t panic if the result is low — just repeat the test with support from your team

🩺 Why This Matters

Getting the right amount of posaconazole in your body is essential to:

  • Help clear fungal infection

  • Prevent it from spreading

  • Reduce symptoms like coughing, breathlessness, and mucus

  • Avoid the risk of fungal resistance

💬 Talk to Your Healthcare Team

If you’re concerned about your levels or not feeling better, don’t stop your medication — contact your team. There may be a simple fix like adjusting your dose, changing the form of medicine, or switching how and when you take it.

📘 For more information

Visit: www.aspergillosis.org
Or speak to your GP, pharmacist, or specialist team.

by GAtherton

🧭 Self-Health Management: Then, Now, and What’s Coming Next

🧭 Self-Health Management: Then, Now, and What’s Coming Next

Over the past 20 years, the way people manage their health in the UK has changed dramatically — and more changes are on the horizon. For people living with long-term or complex conditions like aspergillosis, asthma, or chronic lung disease, this shift has brought both new opportunities and new burdens.

This article explains what’s changed, what the government is planning, what benefits are hoped for — and what happens if you can’t or don’t want to use online tools.

🕰️ What Was Self-Health Management Like 20 Years Ago?

In the early 2000s:

  • Patients relied heavily on their GP or hospital specialist for every decision.

  • Access to records was limited or non-existent.

  • Health information came from leaflets, GPs, or occasional TV programmes.

  • Appointments were mostly face-to-face and arranged by phone.

  • There was less expectation for people to self-manage complex conditions.

📲 What’s Different Today?

Patients today are expected to:

  • Track symptoms themselves and know when to seek help.

  • Use digital tools like the NHS App, online consultations, and health monitoring apps.

  • Interpret test results, medication side effects, and care plans with less direct support.

  • Coordinate care between services — sometimes across different hospitals or systems.

  • Understand and act on complex health advice, often with less contact from clinicians.

For people with chronic respiratory conditions like CPA or ABPA, this can sometimes improve control — but it can also feel overwhelming, especially when care is fragmented or specialists are hard to reach.

🧑‍⚕️ How Are Healthcare Staff Adapting?

Many GPs, nurses, and hospital teams are trying to:

  • Embrace shared decision-making and educate patients more directly.

  • Offer video, phone, or online consultations when appropriate.

  • Provide tools like self-monitoring diaries, peak flow meters, or oxygen saturation monitors.

  • Rely on electronic triage systems and limit in-person appointments to the most complex cases.

But many are also under pressure. Staff shortages, long waiting lists, and increased demand mean clinicians have less time per patient, making it harder to offer the detailed guidance many people still need.

🏛️ What Is the UK Government Planning for the Future?

The government’s current plans aim to make the NHS more digital, preventative, and self-directed. This is laid out in the NHS Long Term Plan, the Digital Health and Care Strategy, and the Data Saves Lives policy.

Goal Target
Make the NHS App the main access point for care 2025–2026
Move more routine care to remote monitoring and self-management By 2026–2029
Personalise prevention and reduce avoidable illness By 2029
Reduce reliance on face-to-face appointments Ongoing since 2021
Digitise health records across all services By 2025–2027

Patients with long-term conditions are expected to:

  • Manage their own prescriptions

  • Monitor symptoms at home

  • Use digital tools to stay informed and in control

  • Access care only when needed, rather than by default

🎯 What Are the Hoped-For Benefits?

The government promotes these changes as delivering:

✅ Better Outcomes

  • Early intervention, better symptom tracking, and fewer complications.

  • Personalised care plans based on your data and condition.

✅ More Convenient Care

  • Fewer unnecessary visits

  • More control over your own information and appointments

✅ NHS Cost Savings

  • Reducing face-to-face appointments and hospital stays frees up staff time.

  • Less duplication, fewer unnecessary tests, better resource use.

⚠️ But Is It Better for Everyone?

Not necessarily. These benefits are not equally felt by all patients.

🧓 Digital Exclusion Is a Real Problem

  • Around 1 in 5 UK adults struggle with using digital health services.

  • Older adults, people on low incomes, and those with disabilities or learning needs are most affected.

  • Some patients simply don’t feel confident, or don’t trust digital systems.

🧭 What Happens If You’re Left Behind?

Government guidance insists that non-digital options must remain — but this isn’t always consistent. Some patients report:

  • Difficulty reaching practices by phone

  • Online-only booking or consultations

  • Fewer letters and face-to-face reviews

Patients with complex, fluctuating, or rare conditions like aspergillosis may find it harder to get appropriate support without a strong digital presence — especially if care crosses multiple departments or regions.

🧠 So What Needs to Happen?

To make this shift work for everyone, the system must:

  • Protect non-digital access routes (e.g. phone, letter, face-to-face)

  • Offer digital training and support to those who want it

  • Make sure apps and online tools are inclusive and easy to use

  • Involve patients in designing these services — especially those with long-term conditions

  • Keep monitoring for harm or exclusion, and respond quickly

📍 Where Can Patients Get Help Today?

Support Type Where to Find It
🔬 Specialist advice National Aspergillosis Centre, hospital respiratory clinics
👨‍⚕️ Local support GP, pharmacist, practice nurse
📱 Digital tools NHS App, condition-specific apps, NHS websites
🤝 Peer support Online groups, charities, forums (e.g. Asthma + Lung UK, aspergillosis.org)
💬 Advice lines NHS 111, condition-specific helplines

✅ In Summary

The NHS is changing — and patients are expected to change with it. Over 20 years, self-management has gone from optional to expected, and digital care is being rapidly expanded.

For some, this means more control and quicker help. For others, it can feel isolating, confusing, or unsafe. The challenge is to design systems that support everyone — not just the tech-savvy or well-connected.

If you’re living with a long-term condition like aspergillosis, you should never be left managing alone.

by GAtherton

🧾 Getting a Second Opinion for Aspergillosis: What If Your Hospital Refuses?

Many patients living with aspergillosis or allergic bronchopulmonary aspergillosis (ABPA) ask for a second opinion — often from a national centre like the National Aspergillosis Centre (NAC) in Manchester or from another specialist elsewhere in the UK. But sometimes, hospitals resist sending your case outside their own department.

Here’s what’s happening, why it might occur, and what you can do.

🤔 Why Would a Hospital Refuse an Outside Opinion?

It’s understandably frustrating when you’ve asked for expert help and your local hospital insists on keeping things “in-house.” Here are some reasons this might happen:

1. Internal Referral Rules

Hospitals sometimes have a policy to refer to another consultant within their own department first. They may consider this a “second opinion,” even if it’s not truly independent.

2. Cost and Complexity

Referrals to another NHS trust — especially across health boards or into England (e.g. to NAC) — can involve extra steps and costs. Some hospitals prefer to avoid that unless they feel there’s no choice.

3. Professional Sensitivities

Some doctors may feel a national second opinion implies criticism of their care, even if your request is made respectfully.

4. Lack of Awareness

Some clinicians aren’t fully aware of what the National Aspergillosis Centre offers — or may underestimate how complex aspergillosis, ABPA, or recurrent fungal infections can be.

🧑‍⚕️ But Isn’t a Specialist Opinion My Right as an NHS Patient?

Yes. If your GP or hospital team believes it’s clinically appropriate, you have the right to be referred to another NHS consultant — including one outside your local area.

The NAC is nationally commissioned by NHS England to provide care for people with chronic aspergillosis. They accept referrals from across the UK.

💷 Why Private Care Might Not Be an Option

Some patients consider going private when local NHS referrals are blocked — but private care often means:

  • Paying for new scans, blood tests, and sputum cultures

  • No direct access to previous NHS records

  • Higher costs than expected, especially for complex tests

If you can’t afford this, you are not alone, and there are still NHS options available.

🧭 What You Can Do Next

Here are practical steps if you're being blocked from getting a second opinion:

✅ 1. Restate Your Request Clearly

Ask your GP (or write yourself) to reply to the hospital and explain:

  • You are specifically asking for an opinion from a national expert service (e.g. NAC or Dr Iain Page in Edinburgh).

  • This is not a rejection of their care, but a request for specialist reassurance, diagnosis support, or treatment planning.

✅ 2. Ask for a Tertiary Centre Referral

Use the term “tertiary referral” — this means a referral to a national or highly specialised NHS service.

✅ 3. Raise It with PALS

If you're still being blocked, contact your local Patient Advice and Liaison Service (PALS) or NHS complaints team. Explain:

  • You have a rare/complex condition,

  • You’ve asked for a national review,

  • And you’ve been offered only an internal opinion.

✅ 4. Get support on NAC Support Facebook Group

  • https://www.facebook.com/groups/aspergillussupport/

💬 In Summary

  • You’re not being difficult — you’re advocating for your health.

  • It is reasonable and often necessary to seek input from specialists like those at the NAC.

  • If you’ve been told “no,” it may be due to policies or misunderstandings — not a reflection on your need for better care.

  • Keep asking, and if needed, involve your GP, or PALS.

by GAtherton

🫁 The FeNO Test: What It Means for People with Aspergillosis

If you have aspergillosis, particularly ABPA (Allergic Bronchopulmonary Aspergillosis) or overlapping asthma, your doctor might suggest a test called FeNO. But what is it—and is it useful for people like you?

This guide explains the FeNO test in simple terms, how it works in patients with aspergillosis, and what to expect from the results.

🔍 What Is the FeNO Test?

FeNO stands for Fractional Exhaled Nitric Oxide. It’s a quick and painless breathing test that measures the level of nitric oxide gas in your breath.

Nitric oxide is naturally produced in your lungs. When your airways are inflamed—especially with eosinophilic (type 2) inflammation—levels go up.

This kind of inflammation is common in:

  • Asthma

  • Allergic Bronchopulmonary Aspergillosis (ABPA)

  • Some cases of chronic aspergillosis with allergic features

🎯 Why Might Aspergillosis Patients Be Offered a FeNO Test?

Your team might use FeNO to:

  • Support a diagnosis of ABPA or allergic asthma

  • Monitor inflammation levels over time

  • Check if inhaled steroids are working

  • Help plan changes to your treatment

FeNO can help show how much inflammation is active in your lungs, even if your symptoms haven’t changed much.

📈 Is the FeNO Test Accurate?

FeNO is a proven and recommended tool in asthma and allergic lung disease, including ABPA. But it works best when used alongside other information—such as:

  • Blood tests (like total and specific IgE)

  • CT scans

  • Lung function tests

  • Sputum cultures and fungal markers

So FeNO doesn’t give a “yes” or “no” answer by itself. It’s part of the bigger picture.

⚠️ What Can Affect the Results?

Certain things can raise or lower your FeNO level:

  • Smoking (lowers it)

  • Recent steroid use (lowers it)

  • Recent infections

  • Foods rich in nitrates (like beetroot, spinach)

  • ABPA flares (may raise it)

This is why your clinician will always interpret your FeNO result in context.

🩺 Should You Trust It?

Yes — when interpreted by an experienced team, FeNO is a safe and useful tool. It helps in understanding how allergic inflammation behaves in your lungs, especially if you're living with ABPA or asthma alongside aspergillosis.

✅ Summary for Aspergillosis Patients

  • FeNO is helpful in allergic forms of aspergillosis, like ABPA

  • It measures airway inflammation, especially type 2 (eosinophilic) inflammation

  • It helps guide treatment with inhaled steroids or biologics

  • It’s not a stand-alone test—it’s used together with other clinical information

  • If you’re unsure what your FeNO result means, just ask your care team

If you’re being treated at the National Aspergillosis Centre, or referred for specialist care, FeNO testing may be used to help plan or fine-tune your treatment.

by GAtherton

🌿 Living with Chronic Pulmonary Aspergillosis (CPA):

Hope, Setbacks, and What “Cure” Really Means

Being diagnosed with chronic pulmonary aspergillosis (CPA) is often overwhelming. You may be on treatment with antifungals like itraconazole (Sporanox) and have already gone through ups and downs — early improvement, then a period of stagnation, and now you're facing a new CT scan with anxiety.

You’re not alone — and this guide brings together the key questions patients often ask, along with helpful real-life insights.

✅ “I Felt Better at First — Then It Stalled. Why?”

This is very common in CPA. In the first few months:

  • Symptoms like cough, breathlessness, and fatigue may improve.

  • CT scans may show fungal balls shrinking or disappearing.
    But then:

  • Symptoms return or stay the same.

  • Scans show little change.

  • Anxiety grows.

This doesn’t mean treatment has failed.
It may just mean you've reached a slower phase of healing. Here's why:

Reason What’s Happening
Antifungal success at first Fungal load drops, but scarring and inflammation remain.
Itraconazole is working But drug levels may be too low — monitoring is essential.
Other lung conditions coexist Like bronchiectasis or NTM, which antifungals don’t treat.
Ongoing exposure to mould Especially from damp buildings, compost, or dust.
Immune response adapts Symptoms may persist even if fungus is under control.

🔁 “Can Things Improve Again?”

Yes — many people improve again after a plateau or setback.

What helps:

  • ✅ Check your itraconazole blood level — low levels = poor response.

  • ✅ Consider a switch to another antifungal, like voriconazole or posaconazole.

  • ✅ Ask your team about co-infections, inhaled therapies, or lung physiotherapy.

  • ✅ Monitor your vitamin D, weight, and steroid use (to rule out other causes of symptoms).

  • ✅ Keep going — many people improve again with time, adjustments, and support.

🗣️ “I had a dip after three months. We checked my drug levels — they were low. After a small dose change, I felt better again.” — Patient story

💬 “Can CPA Be Cured?”

🩺 What Do We Mean by “Cure”?

In medicine, a cure usually means:

  • The disease is gone,

  • Treatment is no longer needed,

  • There’s no sign of the illness coming back.

But in CPA, a full cure is rare — because the conditions that allowed it to take hold usually remain.

⚠️ Why CPA Is Rarely “Cured” in the Traditional Sense

  • CPA often happens in lungs already damaged by:

    • Tuberculosis (TB)

    • COPD or emphysema

    • Bronchiectasis

    • Allergic bronchopulmonary aspergillosis (ABPA)
      These conditions are chronic and don’t disappear, even if the fungus is controlled.

  • Scars, cavities, and weakened lung tissue remain, and symptoms can return if antifungal treatment is stopped too soon or if reinfection occurs.

✅ So What’s a More Accurate Way to Think About It?

Instead of talking about a cure, specialists use words like:

Term What It Means
Clinical improvement You feel better, symptoms reduce, scans look more stable.
Stability The disease is under control — not progressing.
Remission The infection is quiet or inactive — with or without treatment.
Disease control Long-term treatment is helping manage the condition safely.

📌 Think of CPA like asthma or diabetes — not "gone," but often well controlled.

🟢 Sometimes — CPA can be cured

In a small number of people:

  • The fungus is cleared completely,

  • Symptoms resolve,

  • Antifungals are stopped and not needed again.

This is more likely when:

  • CPA is caught early,

  • The disease is limited to one area,

  • The person has otherwise healthy lungs.

🟡 For Most — CPA is treatable but long-term

You may not fully “get rid of it” — but you can:

  • Live well with it,

  • Keep symptoms under control,

  • Avoid major complications.

🔴 If untreated, CPA can progress

  • Damage spreads,

  • Bleeding may worsen,

  • General health may decline.

That’s why staying on treatment and having regular check-ups is so important.

🔪 What About Surgery?

Surgery can help in some cases — but it depends on your specific situation.

🟢 Surgery may help if:

  • You have a single aspergilloma (fungal ball).

  • You're experiencing repeated bleeding (haemoptysis).

  • The lesion is growing or pressing on nearby structures.

  • Antifungals haven’t worked, or aren’t tolerated.

In these cases, removing part of the lung may stop bleeding, reduce symptoms, and improve quality of life.

🔴 Surgery may not be suitable if:

  • Disease affects both lungs or multiple areas.

  • Your lung function is too low.

  • The lesion is too close to vital structures.

  • You have underlying conditions like COPD, bronchiectasis, or ABPA that wouldn’t improve after surgery.

🩺 If surgery isn’t an option:

You may still benefit from:

  • Bronchial artery embolisation (BAE) — a non-surgical way to stop bleeding.

  • Ongoing antifungal therapy.

  • Symptom management through breathing support and physiotherapy.

💬 What Other Patients Say

Patient Story Outcome
“My fungal ball vanished after 6 months. I’m still on meds but doing well.” Stable with long-term itraconazole
“I plateaued, then improved again after switching drugs.” Switched to posaconazole
“I had surgery after coughing up blood for months. It made a huge difference.” Surgery successful
“I live with scarring, but I’m off meds now and stable.” Clinical remission

🧾 What You Can Do

  • ✅ Ask your doctor to check your itraconazole level if not already done.

  • ✅ Record weekly symptoms — cough, fatigue, breathlessness.

  • ✅ Ask about sputum tests for fungi or bacteria.

  • ✅ Discuss surgery or embolisation if you’re coughing up blood.

  • ✅ Stay hopeful — CPA is manageable, and some people do recover.

❤️ Final Thoughts

CPA is rarely curable in the strictest sense, but that doesn’t mean it’s hopeless.
Many people live full lives with the disease under control. Even if CT scans show lasting changes, what really matters is:
How you feel. How well you breathe. How stable your condition stays.

With antifungal therapy, expert care, and the right support, you are not alone — and you can feel better again.

by GAtherton

Article 4: Why This New Information on Biofilms Can Be Reassuring — Not Frightening

💬 A Message to Patients: Why This New Information Can Be Reassuring — Not Frightening

We understand that learning about things like biofilms, the lung microbiome, or how different bugs work together might feel a little overwhelming or even alarming. These topics are complex and unfamiliar to many.

But we want you to know: this science is already improving care for people with aspergillosis — and you don’t need to understand every detail for it to help you.

✅ Examples of How Biofilm Awareness Is Already Helping Patients

🧪 1. Combined Treatment for Coinfection

People who have both Aspergillus and Pseudomonas infections are now more likely to be:

  • Tested for both microbes

  • Given combination therapy (e.g. antifungals + inhaled antibiotics)
    This reduces the risk of persistent symptoms and lowers the chance of hospital admission.

🌬 2. Inhaled Therapies That Reach Biofilms

Doctors are now using or trialling inhaled medications that can:

  • Reach fungal and bacterial biofilms more directly

  • Work even when oral drugs can’t penetrate
    For example, inhaled colistin or tobramycin is used in bronchiectasis; inhaled antifungals (like opelconazole) are in trials for aspergillosis.

💡 3. Chest Physiotherapy and Mucus Clearance

Biofilm research has shown that many infections hide in thick mucus. So, clearing mucus isn't just for comfort — it’s a critical part of treatment.

  • More patients now receive airway clearance devices

  • Some are referred for specialist physiotherapy to support this

🧼 4. Better Infection Control in Hospital

Because we understand that biofilms form on equipment and even in hospital air systems, specialist centres like NAC use:

  • HEPA-filtered rooms

  • Strict protocols to prevent airborne contamination
    This lowers the risk of acquiring new fungal infections during hospital stays.

📊 5. More Personalised Care

Some patients now receive tailored treatment plans based on:

  • Sputum cultures that show which organisms are present

  • Whether biofilm-forming species are involved

  • Coexisting inflammation, allergies, or colonisation patterns

This is a big shift from one-size-fits-all prescriptions.

💬 Final Reassurance

These discoveries don’t mean there’s something worse going on. They mean that:

  • Doctors now understand more

  • Treatments are becoming more precise

  • We can often treat fewer times, more effectively

You're not alone — and you're not expected to keep up with every detail. This information helps your care team make better choices for you, reduce flare-ups, and improve quality of life. And that’s what really matters.

by GAtherton

📝 Article 3: When Microbes Work Together – Aspergillus, Pseudomonas, and Lung Inflammation

🤝 Not all microbes are rivals — some collaborate

Recent research shows that Aspergillus fumigatus and Pseudomonas aeruginosa can cooperate, particularly in people with weakened lungs or structural damage (e.g. from bronchiectasis, CF, or CPA).

Examples of how they interact:

  • Pseudomonas produces toxins (phenazines) that sometimes stimulate Aspergillus growth in low doses

  • Aspergillus produces substances like gliotoxin that weaken immune responses and protect both microbes

  • Both can form mixed biofilms, making them more drug-resistant and more inflammatory

⚠️ Clinical implications:

Coinfection with Aspergillus and Pseudomonas is associated with:

  • Worse lung function in CF, bronchiectasis, CPA

  • More frequent exacerbations and hospital admissions

  • Longer recovery times and lower quality of life

🧠 Why is this important for treatment?

Doctors are now:

  • Testing for multiple microbes during exacerbations

  • Using combination therapy — antifungals and antibiotics together

  • Supporting the immune system with:

    • Airway clearance

    • Nutrition

    • Steroid balancing (not too much, not too little)

🧬 New tools on the horizon:

  • Drugs that block microbial signalling (quorum sensing)

  • Microbiome profiling to predict flare-ups

  • Biofilm-dissolving agents in development

  • Inhaled antifungals under trial (e.g. opelconazole)

🌟 Final Summary: A Shift in Perspective

Old Approach New, Holistic Approach
Target a single infection Understand the whole lung ecosystem
Treat only during active infection Focus on prevention, balance, resilience
One-size-fits-all antibiotic use Tailored therapy, minimise microbiome damage
Ignore biofilms Disrupt biofilms and support mucus clearance
Fungal and bacterial issues separate Recognise synergy and co-infection

by GAtherton

📝 Article 2: The Lung Microbiome – More Than Just Aspergillus

🌱 What is the lung microbiome?

The lung microbiome is the collection of bacteria, fungi, and viruses that naturally live in your respiratory system. For a long time, lungs were thought to be sterile — we now know that they host complex microbial communities, even in healthy people.

In people with chronic lung conditions like CPA, ABPA, asthma, bronchiectasis, and cystic fibrosis, the lung microbiome can become unbalanced. Certain harmful microbes may overgrow, while beneficial ones disappear.

🤝 Why is this important?

The balance of microbes in your lungs affects:

  • How your immune system responds

  • Whether inflammation is triggered or controlled

  • How easily infections take hold

In aspergillosis patients:

  • Disruption of the microbiome may encourage fungal growth

  • Frequent antibiotics (for chest infections) can kill good bacteria, giving fungi and drug-resistant bacteria an advantage

  • Some microbes may protect against Aspergillus or help modulate inflammation

This is particularly important during flare-ups and exacerbations.

🧪 What are researchers doing?

Lung microbiome research is growing rapidly. Scientists are:

  • Identifying "protective" microbes that might reduce disease severity

  • Studying how antibiotics, steroids, and antifungals alter the microbiome

  • Investigating faecal or airway microbiota transplants in severe lung disease

  • Developing tests that detect imbalances in lung flora before symptoms worsen

💡 What can you do as a patient?

  • Avoid unnecessary or repeated broad-spectrum antibiotics unless clearly needed

  • Use airway clearance techniques to keep mucus and debris low

  • Ask your clinician if your sputum cultures test for both bacteria and fungi

  • Consider probiotics cautiously, though evidence for lung benefit is still limited

by GAtherton